18 March 2021

Ankylosing Spondylitis Biologics Cognitive Therapies

FDA approves Actemra for scleroderma lung

18 March 2021

Cognitive Therapies Exercise

How to help scleroderma patients get more active

10 March 2021

Conditions Research Spondyloarthritis

Biobank paves future for musculoskeletal research

10 March 2021

Biologics Conditions Pharmaceuticals

New shingles vaccine more effective

10 March 2021

Patient Education Rural

More medical graduates won’t fix rural shortages

10 March 2021

Conditions Research Women

Tackling gender bias in medicine

10 March 2021

DMARDS Practice Management

Don’t fall foul of the ATO on income splitting

10 March 2021

Reactive Arthritis Technology

Deciphering lupus with machine learning

10 March 2021

Biologics Communicable Diseases Gout Spondyloarthritis

RA patients report upadacitinib equal to or better than adalimumab

5 March 2021

Gout Spondyloarthritis TGA

Gilead pulls plug on filgotinib for Australian RA patients

4 March 2021

NSAIDS

Not everything was better in the good old days

3 March 2021

Ankylosing Spondylitis

Impressive results for bimekizumab in plaque psoriasis trial

3 March 2021

Exercise osteomyelitis Spondyloarthritis

Barriers to exercise – targeting RA patients who most need help

3 March 2021

Conditions Spondyloarthritis

Anti-CCP and diagnosing rheumatoid arthritis

3 March 2021

Conditions Rheumatoid Arthritis

Stem cell trial asks the big OA question

3 March 2021

Conditions

What’s in a named referral? Money